Marrone Bio Innovations Issues Shareholder Letter
Marrone Bio Innovations Issues Shareholder Letter
DAVIS, Calif., Feb. 03, 2021 Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, today released a letter to shareholders from Chief Executive Officer, Kevin Helash.
Dear Shareholders:
There is a rhythm to agriculture that is predictable even in unpredictable times. The first half of the year starts strong, as Southern Hemisphere row crops mature and move toward harvest. In the Northern Hemisphere, orchards are being pruned and prepped for bud set and pollination. Row crop farmers are finalizing seed and input selections, cautiously optimistic right now as crop prices have been recovering with better global trading patterns.
Basilea Pharmaceutica AG: Basilea gibt vorläufige Umsatzzahlen für 2020 bekannt und berichtet über Fortschritte im Portfolio
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
DGAP-Adhoc: Dürr Aktiengesellschaft: Dürr erweitert Automatisierungsgeschäft durch Mehrheitsbeteiligung an Teamtechnik
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.